Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients

Clinical trial NCT00420290 · COMPLETED

Trial details

NCT number: NCT00420290
Sponsor: Vanderbilt University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2008-01-01
Primary completion: 2010-05-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.